Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Xyzal
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 56
2018 Revenue in Millions : 45
Growth (%) : 24
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : -8
2019 Revenue in Millions : 62
Growth (%) : -114
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 110
2018 Revenue in Millions : 98
Growth (%) : 12
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 90
2019 Revenue in Millions : 122
Growth (%) : -27
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 62
2020 Revenue in Millions : 90
Growth (%) : -24
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 62
2022 Revenue in Millions : 61
Growth (%) : 0
Levocetirizine Dihydrochloride
Main Therapeutic Indication : Anti-Allergic
Currency : USD
2018 Revenue in Millions : 102
2017 Revenue in Millions : 118
Growth (%) : -13%
LOOKING FOR A SUPPLIER?